单核酸多态化是否未被充分利用,用于指导炎症性肠病的治疗?
Jildou van der Werf1, Nicholas Ian Fleming1,2
1Department of Pathology, University of Otago, Dunedin, New Zealand.
Immunology and cell biology
|May 2, 2025
概括
单核酸多态 (SNP) 影响炎症性肠病 (IBD),但与预测治疗反应的单核酸多态基本不同. 进一步研究以治疗为重点的SNP可以解锁个性化的IBD治疗策略.
科学领域:
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
背景情况:
- 炎症性肠病 (IBD),包括克罗恩病和性结肠炎,显著影响患者的生活质量.
- 遗传变异,特别是单核酸多态 (SNP),有助于IBD治疗中观察到的多样化的反应.
- 目前的IBD管理面临着挑战,原因是治疗疗效的个体间变化.
研究的目的:
- 审查使用SNP指导IBD患者治疗决策的证据.
- 探索SNP在IBD病变发生中的作用及其对免疫功能和屏障完整性的影响.
- 评估SNP在预测对现有和新型IBD治疗方法的反应方面的有用性.
主要方法:
- 审查有关SNP和IBD现有的科学文献.
- 分析与IBD病原发生相关的SNP,包括影响上皮质屏障完整性和免疫反应的SNP.
- 检查与IBD治疗的疗效相关的SNP,如乌斯特基努马布和托法西提尼布.
- 探索研究较少的SNP与复杂的疾病关系.
主要成果:
- 强烈与IBD病变发生相关的SNP通常与预测治疗反应的SNP不同.
- 某些SNP会影响与IBD相关的关键生物通路,例如细胞因子的产生和免疫系统的功能.
- 有证据表明,涉及治疗反应的SNP通常是治疗特异性的.
结论:
- 基于SNP的IBD个性化治疗策略目前未得到充分利用.
- 以治疗为重点的研究具有显著的潜力,可以在IBD管理中发现新的药物遗传工具.
- 未来的研究应该优先确定SNP,这些SNP可以准确预测个体患者对特定IBD疗法的反应.
相关概念视频
01:29Inflammatory Bowel Disease IV: Pharmacological Management
79
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
79
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
223
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
223
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
100
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
100
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
97
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
97
01:29Drugs for Treatment of Ulcerative Colitis in IBD
102
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
102
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
86
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
86